SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Silencing information regulator 1 (SIRT1) was demonstrated to modulate cholesterol and lipid metabolism in NAFLD. Here, a novel SIRT1 activator, E1231, was studied for its potential improvement effects on NAFLD. C57BL...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jiangxue, Li, Shunwang, Wang, Weizhi, Jiang, Xinhai, Liu, Chao, Lei, Lijuan, Li, Yining, Sheng, Ren, Zhang, Yuyan, Wu, Yexiang, Zhang, Jing, Zhang, Yuhao, Xu, Yanni, Si, Shuyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297637/
https://www.ncbi.nlm.nih.gov/pubmed/37367070
http://dx.doi.org/10.3390/cimb45060321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297637/
https://www.ncbi.nlm.nih.gov/pubmed/37367070
http://dx.doi.org/10.3390/cimb45060321

Ejemplares similares